The Biology of Aging: Citizen Scientists and Their Pets as a Bridge Between Research on Model Organisms and Human Subjects

Veterinary Pathology

Volumn 53, Issue 2, 2016, Pages 291-298

  Kaeberlein, M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

caloric restriction; dietary restriction; dogs; health span; life span; mechanistic target of rapamycin; mice; sirtuins; target of rapamycin

Indexed keywords

AGING; ANIMAL; ANIMAL MODEL; HUMAN; LABORATORY PERSONNEL; LONGEVITY; MOUSE; PET ANIMAL; PHYSIOLOGY; QUALITY OF LIFE; RESEARCH;

AGING; ANIMALS; HUMANS; LABORATORY PERSONNEL; LONGEVITY; MICE; MODELS, ANIMAL; PETS; QUALITY OF LIFE; RESEARCH;

EID: 84960087118     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985815591082     Document Type: Article

References (100)

1. R.M.AndersonR.Weindruch. The caloric restriction paradigm: implications for healthy human aging. Am J Hum Biol. 2012;24(2):101–106.
2. V.N.AnisimovA.Bartke. The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer. Crit Rev Oncol Hematol. 2013;87(3):201–223.
3. V.N.AnisimovM.A.ZabezhinskiI.G.Popovich. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle. 2011;10(24):4230–4236.
4. J.ApfeldG.O’ConnorT.McDonaghThe AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C elegans. Genes Dev. 2004;18(24):3004–3009.
5. A.Bartke. Pleiotropic effects of growth hormone signaling in aging. Trends Endocrinol Metab. 2011;22(11):437–442.
6. I.BjedovJ.M.ToivonenF.Kerr. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab. 2010;11(1):35–46.
7. M.V.Blagosklonny. Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to. Aging. 2012;4(5):350–358.
8. M.V.Blagosklonny. Rapamycin extends life- and health span because it slows aging. Aging (Albany NY). 2013;5(8):592–598.
9. H.Brown-BorgK.BorgC.Meliska. Dwarf mice and the ageing process. Nature. 1996;384(6604):33.
10. J.B.BurchA.D.AugustineL.A.Frieden. Advances in geroscience: impact on healthspan and chronic disease. J Gerontol A Biol Sci Med Sci. 2014;69(suppl 1):S1–S3.
11. A.CaccamoS.MajumderA.Richardson. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J Biol Chem. 2010;285(17):13107–13120.
12. E.Check Hayden. Pet dogs set to test anti-ageing drug. Nature. 2014;514(7524):546.
13. C.ChenY.LiuP.Zheng. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci Signal. 2009;2(98):ra75.
14. D.J.ClancyD.GemsL.G.Harshman. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science. 2001;292(5514):104–106.
15. R.J.ColmanR.M.AndersonS.C.Johnson. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009;325(5937):201–204.
16. R.J.ColmanT.M.BeasleyJ.W.Kemnitz. Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys. Nat Commun. 2014;5:3557.
17. K.CoschiganoD.ClemmonsL.Bellush. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology. 2000;141(7):2608–2613.
18. D.F.DaiP.P.KarunadharmaY.A.Chiao. Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart. Aging Cell. 2014;13(3):529–539.
19. D.EhningerF.NeffK.Xie. Longevity, aging and rapamycin. Cell Mol Life Sci. 2014;71(22):4325–4346.
20. P.FabrizioF.PozzaS.D.Pletcher. Regulation of longevity and stress resistance by Sch9 in yeast. Science. 2001;292(5515):288–290.
21. G.FernandesE.J.YunisR.A.Good. Influence of diet on survival of mice. Proc Natl Acad Sci U S A. 1976;73(4):1279–1283.
22. J.M.FlemingK.E.CreevyD.E.Promislow. Mortality in north american dogs from 1984 to 2004; an investigation into age-, size-, and breed-related causes of death. J Vet Intern Med. 2011;25(2):187–198.
23. K.FlurkeyJ.PapaconstantinouR.Miller. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci U S A. 2001;98(12):6736–6741.
24. J.M.FlynnM.N.O’LearyC.A.Zambataro. Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell. 2013;12(5):851–862.
25. W.C.FokY.ChenA.Bokov. Mice fed rapamycin have an increase in lifespan associated with major changes in the liver transcriptome. PLoS One. 2014;9(1):e83988.
26. D.B.FriedmanT.E.Johnson. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics. 1988;118(1):75–86.
27. S.FuscoG.Pani. Brain response to calorie restriction. Cell Mol Life Sci. 2013;70(17):3157–3170.
28. W.GiblinM.E.SkinnerD.B.Lombard. Sirtuins: guardians of mammalian healthspan. Trends Genet. 2014;30(7):271–286.
29. D.P.GoldmanD.CutlerJ.W.Rowe. Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood). 2013;32(10):1698–1705.
30. J.HalloranS.HussongR.Burbank. Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice. Neuroscience. 2012;223:102–113.
31. J.M.HarperC.W.LeathersS.N.Austad. Does caloric restriction extend life in wild mice?Aging Cell. 2006;5(6):441–449.
32. D.E.HarrisonR.StrongZ.D.Sharp. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392–395.
33. M.HolzenbergerJ.DupontB.Ducos. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 2003;421:182–189.
34. S.ImaiC.M.ArmstrongM.Kaeberlein. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000;403(6771):795–800.
35. S.C.JohnsonG.M.MartinP.S.Rabinovitch. Preserving youth: does rapamycin deliver?Sci Transl Med. 2013;5(211):211fs40.
36. S.C.JohnsonM.SangeslandM.Kaeberlein. Modulating mTOR in aging and health. Interdiscip Top Gerontol. 2015;40:107–127.
37. S.C.JohnsonM.E.Yanos, Kayser EB, mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science. 2013;342(6165):1524–1528.
38. R.K.JunnilaE.O.ListD.E.Berryman. The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol. 2013;9(6):366–376.
39. M.Kaeberlein. Longevity and aging. F1000Prime Rep. 2013;5:5.
40. M.Kaeberlein. mTOR inhibition: from aging to autism and beyond. Scientifica (Cairo). 2013;2013:849186.
41. M.Kaeberlein. Rapamycin and ageing: when, for how long, and how much?J Genet Genomics. 2014;41(9):459–463.
42. M.KaeberleinB.K.Kennedy. Ageing: a midlife longevity drug?Nature. 2009;460(7253):331–332.
43. M.KaeberleinM.McVeyL.Guarente. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 1999;13(19):2570–2580.
44. M.KaeberleinR.W.Powers3rdK.K.Steffen. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science. 2005;310(5751):1193–1196.
45. A.E.KaneS.N.HilmerD.BoyerImpact of longevity interventions on a validated mouse clinical frailty index[published online February 22, 2015]. J Gerontol A Biol Sci Med Sci.
46. Y.KanfiS.NaimanG.Amir. The sirtuin SIRT6 regulates lifespan in male mice. Nature. 2012;483(7388):218–221.
47. P.KapahiB.M.ZidT.Harper. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol. 2004;14(10):885–890.
48. B.KaplanY.QaziJ.R.Wellen. Strategies for the management of adverse events associated with mTOR inhibitors. Transplant Rev (Orlando). 2014;28(3):126–133.
49. B.K.KennedyS.L.BergerA.Brunet. Geroscience: linking aging to chronic disease. Cell. 2014;159(4):709–713.
50. B.K.KennedyK.K.SteffenM.Kaeberlein. Ruminations on dietary restriction and aging. Cell Mol Life Sci. 2007;64(11):1323–1328.
51. C.KenyonJ.Chang, Gensch E, elegans mutant that lives twice as long as wild type. Nature. 1993;366(6454):461–464.
52. C.J.Kenyon. The genetics of ageing. Nature. 2010;464(7288):504–512.
53. D.W.LammingL.YeP.Katajisto. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science. 2012;335(6076):1638–1643.
54. C.Y.LiaoB.A.RikkeT.E.Johnson. Genetic variation in the murine lifespan response to dietary restriction: from life extension to life shortening. Aging Cell. 2010;9(1):92–95.
55. A.L.LinW.ZhengJ.J.Halloran. Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer’s disease. J Cereb Blood Flow Metab. 2013;33(9):1412–1421.
56. S.J.LinP.A.DefossezL.Guarente. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science. 2000;289(5487):2126–2128.
57. C.Lopez-OtinM.A.BlascoL.Partridge. The hallmarks of aging. Cell. 2013;153(6):1194–1217.
58. J.Y.LuY.Y.LinJ.C.Sheu. Acetylation of yeast AMPK controls intrinsic aging independently of caloric restriction. Cell. 2011;146(6):969–979.
59. W.MairP.GoymerS.D.Pletcher. Demography of dietary restriction and death in Drosophila. Science. 2003;301(5640):1731–1733.
60. S.MajumderA.CaccamoD.X.Medina. Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1beta and enhancing NMDA signaling. Aging Cell. 2012;11(2):326–335.
61. G.M.Martin. Frontiers of aging. Science. 2001;294(5540):13.
62. A.Martin-MontalvoE.M.MerckenS.J.Mitchell. Metformin improves healthspan and lifespan in mice. Nat Commun. 2013;4:2192.
63. E.J.Masoro. Overview of caloric restriction and ageing. Mech Ageing Dev. 2005;126(9):913–922.
64. J.A.MattisonG.S.RothT.M.Beasley. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature. 2012;489(7415):318–321.
65. C.M.McCayM.F.CrowellL.A.Maynard. The effect of retarded growth upon the length of life and upon ultimate size. J Nutr. 1935;10:63–79.
66. R.A.MillerD.E.HarrisonC.M.Astle. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2011;66(2):191–201.
67. R.A.MillerD.E.HarrisonC.M.Astle. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell. 2014;13(3):468–477.
68. F.NeffD.Flores-DominguezD.P.Ryan. Rapamycin extends murine lifespan but has limited effects on aging. J Clin Invest. 2013;123(8):3272–3291.
69. S.J.OlshanskyD.PerryR.A.Miller. Pursuing the longevity dividend: scientific goals for an aging world. Ann N Y Acad Sci. 2007;1114:11–13.
70. D.OmodeiL.Fontana. Calorie restriction and prevention of age-associated chronic disease. FEBS Lett. 2011;585(11):1537–1542.
71. B.OnkenM.Driscoll. Metformin induces a dietary restriction-like state and the oxidative stress response to extend C elegans healthspan via AMPK, LKB1, and SKN-1. PloS One. 2010;5(1):e8758.
72. J.N.PittM.Kaeberlein. Why is aging conserved and what can we do about it?PLoS Biology. 2015;13(5):e1002176.
73. R.W.Powers3rdM.KaeberleinS.D.Caldwell. Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 2006;20(2):174–184.
74. T.D.PughR.G.KloppR.Weindruch. Controlling caloric consumption: protocols for rodents and rhesus monkeys. Neurobiol Aging. 1999;20(2):157–165.
75. E.K.QuarlesD.F.DaiA.TocchiQuality control systems in cardiac aging[published online February 19, 2015]. Ageing Res Rev.
76. A.Richardson. Rapamycin, anti-aging, and avoiding the fate of Tithonus. J Clin Invest. 2013;123(8):3204–3206.
77. S.Robida-StubbsK.Glover-CutterD.W.Lamming. TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metab. 2012;15(5):713–724.
78. B.RoginaS.L.Helfand. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A. 2004;101(45):15998–16003.
79. A.SatohC.S.BraceN.Rensing. Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab. 2013;18(3):416–430.
80. J.SchleitS.C.JohnsonC.F.Bennett. Molecular mechanisms underlying genotype-dependent responses to dietary restriction. Aging Cell. 2013;12(6):1050–1061.
81. J.SchleitB.M.WaskoM.Kaeberlein. Yeast as a model to understand the interaction between genotype and the response to calorie restriction. FEBS Lett. 2012;586(18):2868–2873.
82. J.E.SchroederJ.C.RichardsonD.J.Virley. Dietary manipulation and caloric restriction in the development of mouse models relevant to neurological diseases. Biochim Biophys Acta. 2010;1802(10):840–846.
83. C.SelmanJ.M.TulletD.Wieser. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science. 2009;326(5949):140–144.
84. C.SlackA.FoleyL.Partridge. Activation of AMPK by the putative dietary restriction mimetic metformin is insufficient to extend lifespan in Drosophila. PLoS One. 2012;7(10):e47699.
85. E.D.SmithT.L.KaeberleinB.T.Lydum. Age- and calorie-independent life span extension from dietary restriction by bacterial deprivation in Caenorhabditis elegans. BMC Dev Biol. 2008;8:49.
86. E.D.SmithB.K.KennedyM.Kaeberlein. Genome-wide identification of conserved longevity genes in yeast and worms. Mech Ageing Dev. 2007;128(1):106–111.
87. J.R.SpeakmanS.E.Mitchell. Caloric restriction. Mol Aspects Med. 2011;32(3):159–221.
88. P.SpilmanN.PodlutskayaM.J.Hart. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer’s disease. PLoS One. 2010;5(4):e9979.
89. S.R.Spindler. Caloric restriction: from soup to nuts. Ageing Res Rev. 2010;9(3):324–353.
90. M.N.StanfelL.S.ShamiehM.Kaeberlein. The TOR pathway comes of age. Biochim Biophys Acta. 2009;1790(10):1067–1074.
91. W.R.Swindell. Dietary restriction in rats and mice: a meta-analysis and review of the evidence for genotype-dependent effects on lifespan. Ageing Res Rev. 2011;11(2):254–270.
92. H.A.TissenbaumL.Guarente. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature. 2001;410(6825):227–230.
93. T.VellaiK.Takacs-VellaiY.Zhang. Genetics: influence of TOR kinase on lifespan in C elegans. Nature. 2003;426(6967):620.
94. A.M.WangD.E.PromislowM.Kaeberlein. Fertile waters for aging research. Cell. 2015;160(5):814–815.
95. D.J.Waters. Aging research 2011: exploring the pet dog paradigm. ILAR J. 2011;52(1):97–105.
96. R.WeindruchR.L.WalfordS.Fligiel. The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J Nutr. 1986;116(4):641–654.
97. J.C.WhiteheadB.A.HildebrandM.Sun. A clinical frailty index in aging mice: comparisons with frailty index data in humans. J Gerontol A Biol Sci Med Sci. 2014;69(6):621–632.
98. J.E.WilkinsonL.BurmeisterS.V.Brooks. Rapamycin slows aging in mice. Aging Cell. 2012;11(4):675–682.
99. J.J.WuJ.LiuE.B.Chen. Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression. Cell Rep. 2013;4(5):913–920.
100. Y.ZhangA.BokovJ.Gelfond. Rapamycin extends life and health in C57BL/6 mice. J Gerontol A Biol Sci Med Sci. 2014;69(2):119–130.